The Bryomixol Treatment...
The Bryomixol Treatment is our contribution to the medical community, but above all to every human being who suffers and lives on a daily basis with cancer. Bryomixol is offered as a supplemental treatment to classic conventional therapies for cancer and other medical conditions. We know that Bryomixol is highly effective and completely devoid of toxic effects. There are no contraindications to its use, and the earlier it is started, the better the results.
PHILOSOPHY
- We believe that man is a spiritual, physical, and mental being, in active interaction with his social, cultural and family environment.
- Over the last 15 years we have come to learn that the problems affecting patients with cancer and other immunosuppressive diseases cannot be resolved solely with the classic traditional medical resources available.
- Despite all the new and revolutionary cancer treatment technologies: chemotherapy, radiotherapy, and surgery, no cure has been found to date for this disease. Faced with this reality, it becomes necessary to focus on a non-toxic natural immunostimulating supplemental treatment that views the patient as a whole being and an individual, helping him to fight his illness and recover his quality of life and personal dignity.
Our History
- Bryomixol formulas were developed in post-war Germany and then taken to South America, where, since the 1980's, it has been used extensively in human medicine. Hundreds of cancer patients have been treated with this medication in South America, with excellent results.
- Bryomixol is a great scientific development and a significant advancement in the area of supplemental and preventive treatment of cancer.
- Certain researchers in the United States have become interested in determining the precise therapeutic value of these new medications, which are capable of curtailing the advance of cancer, without any toxic effect to the patient.
- Clinical testing conducted in vitro, on experimental animals, and on human volunteers has demonstrated the effectiveness of the Bryomixol treatment, as a re-energizer of physical and mental performance, with powerful immunomodulating and immunostimulating characteristic.
Meet Our Specialists
Dr. Cesar Bertacchini
Dr. Cesar Bertacchini is a Board Certified Clinical Oncologist that has treated over 15,000 cancer patients with Bryomixol protocols in over 25 years. He received his Medical Doctorate at the University of Buenos Aires. France’s ministry of foreign affairs selected Dr. Bertacchini as a Fellow and offered him a scholarship to improve studies in clinical oncology at the Lyon University, Paris Pasteur Institute of France. He returned to Argentina, where he served as Professor of Medicine at the University of Buenos Aires and became the Chief of Staff in Oncology at the Hospital Maria Curie in Buenos Aires. He continued to expand his research and studies and founded the South American Organization of Investigation and Treatment of Cancer for the whole South American continent.
In addition to his studies, he has published countless scientific works on chemotherapy for peer review. He was the executive editor of the magazine “Hospital of Oncology Maria Curie” in Argentina. He is often invited to lecture nationally and internationally at conferences and seminars. Today he is the President of Pharmatech in San Salvador, El Salvador.
Dr. Fernando Basail
Fernando C. Basail M.D., M.H.S., P.A.
Vice-President of Pharmatech S.A. de C.V.
Dr. Fernando Basail is a Board Certified Doctor who received the majority of his education in the United States of America. He practiced medicine in California for years before deciding to join Dr. Bertacchini in El Salvador approximately 7 years ago. He received his Medical Doctorate from Cordoba National University in Argentina. Dr. Basail went on to complete his P.A. program in the Family Practice Program at UC Davis Medical School. In addition, he completed his Masters in Health Sciences from Touro University in New York. He currently serves as the Vice President of Pharma Tech.